Chung Wu Investment Group LLC Has $532,000 Position in Cigna Group $CI

Chung Wu Investment Group LLC boosted its position in shares of Cigna Group (NYSE:CI) by 6.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,608 shares of the health services provider’s stock after buying an additional 100 shares during the quarter. Chung Wu Investment Group LLC’s holdings in Cigna Group were worth $532,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Valeo Financial Advisors LLC increased its position in Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Plimoth Trust Co. LLC lifted its holdings in Cigna Group by 4.8% in the second quarter. Plimoth Trust Co. LLC now owns 4,693 shares of the health services provider’s stock valued at $1,551,000 after buying an additional 217 shares during the period. DAVENPORT & Co LLC boosted its stake in Cigna Group by 2.6% in the second quarter. DAVENPORT & Co LLC now owns 5,924 shares of the health services provider’s stock valued at $1,954,000 after acquiring an additional 150 shares during the last quarter. Running Oak Capital LLC grew its holdings in Cigna Group by 3.8% during the 2nd quarter. Running Oak Capital LLC now owns 50,508 shares of the health services provider’s stock worth $16,697,000 after acquiring an additional 1,859 shares during the period. Finally, Grimes & Company Inc. raised its position in shares of Cigna Group by 15.1% during the 2nd quarter. Grimes & Company Inc. now owns 1,442 shares of the health services provider’s stock valued at $477,000 after acquiring an additional 189 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently commented on CI. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Barclays increased their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on shares of Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Finally, Wells Fargo & Company cut their target price on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $371.81.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.70% of the stock is currently owned by insiders.

Cigna Group Stock Performance

NYSE:CI opened at $311.24 on Monday. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock’s 50-day simple moving average is $292.41 and its 200 day simple moving average is $309.65. The firm has a market capitalization of $83.08 billion, a PE ratio of 16.99, a price-to-earnings-growth ratio of 0.91 and a beta of 0.45.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period last year, the company posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were issued a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 1.9%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.